Variable | Relapse | DFS | OS | ||||
---|---|---|---|---|---|---|---|
Univariate | Multivariate (HR) | Univariate | Multivariate (HR) | Univariate | Multivariate (HR) | ||
Donortype | HID vs MSD | P= .034 | P= .047 (0.615) 95%CI 0.381–0.994 | P= .665 | – | P= .832 | – |
Male/female | P= .362 | – | P= .680 | – | P= .433 | – | |
Patient age, ≥ 28 years old vs < 28 years old | P= .183 | – | P= .219 | – | P= .376 | – | |
AML/non-AML | P= .204 | – | P= .518 | – | P= .448 | – | |
Genetics:poor-risk vs others | P= .321 | – | P= .254 | – | P= .489 | – | |
Disease stage at transplants:relapse refractory vs PIF | P= .048 | P= .121 (1.449) 95%CI 0.907–2.314 | P= .084 | P= .148 (1.288) 95%CI 0.914–1.815 | P= .131 | – | |
WBC count at diagnosis:high vs others | P= .659 | – | P= .343 | – | P= .247 | – | |
BM blasts before conditioning, ≥ 32% vs < 32% (median) | P= .191 | – | P= .206 | – | P= .245 | – | |
BM blasts on day 0, ≥ 3% vs < 3% (median) | P= .004 | P= .037 (1.652) 95%CI 1.032-2.640 | P< .001 | P= .005 (1.630) 95%CI 1.162-2.288 | P= .001 | P= .011 (1.573) 95%CI 1.110-2.229 | |
MRD status post-transplant, pos vs neg | P= .002 | P = .003 (2.019) 95%CI 1.267–3.216 | P= .005 | P= .003 (1.668) 95%CI 1.185–2.347 | P= .019 | P= .027 (1.490) 95%CI 1.048–2.121 | |
DLI vs no DLI | P= .025 | P= .034 (0.561) 95%CI 0.329–0.957 | P< .001 | P< .001 (0.402) 95%CI 0.275–0.588 | P< .001 | P< .001 (0.423) 95%CI 0.289–0.620 | |
II-IV aGVHD vs 0-I aGVHD | P= .212 | – | P= .530 | – | P= .558 | – | |
cGVHD vs no cGVHD | P= .003 | P= .023 (0.580) 95%CI 0.363–0.928 | P= .003 | P= .016 (0.659) 95%CI 0.470–0.925 | P= .050 | P= .108 (0.788) 95%CI 0.557–1.116 |